The global burden of illness of peanut allergy: A comprehensive literature review.
Identifieur interne : 000048 ( Main/Corpus ); précédent : 000047; suivant : 000049The global burden of illness of peanut allergy: A comprehensive literature review.
Auteurs : Jay A. Lieberman ; Ruchi S. Gupta ; Rebecca C. Knibb ; Tmirah Haselkorn ; Stephen Tilles ; Douglas P. Mack ; Guillaume PouesselSource :
- Allergy [ 1398-9995 ] ; 2020.
Abstract
Peanut allergy (PA) currently affects approximately 2% of the general population of Western nations and may be increasing in prevalence. Patients with PA and their families/caregivers bear a considerable burden of self-management to avoid accidental peanut exposure and to administer emergency medication (adrenaline) if needed. Compared with other food allergies, PA is associated with higher rates of accidental exposure, severe reactions and potentially fatal anaphylaxis. Approximately 7%-14% of patients with PA experience accidental peanut exposure annually, and one-third to one-half may experience anaphylaxis, although fatalities are rare. These risks impose considerably high healthcare utilization and economic costs for patients with PA and restrictions on daily activities. Measures to accommodate patients with PA are often inadequate, with inconsistent standards for food labelling and inadequate safety policies in public establishments such as restaurants and schools. Children with PA are often bullied, resulting in sadness, humiliation and anxiety. These factors cumulatively contribute to significantly reduced health-related quality of life for patients with PA and families/caregivers. Such factors also provide essential context for risk/benefit assessments of new PA therapies. This narrative review comprehensively assessed the various factors comprising the burden of PA.
DOI: 10.1111/all.14666
PubMed: 33216994
Links to Exploration step
pubmed:33216994Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The global burden of illness of peanut allergy: A comprehensive literature review.</title><author><name sortKey="Lieberman, Jay A" sort="Lieberman, Jay A" uniqKey="Lieberman J" first="Jay A" last="Lieberman">Jay A. Lieberman</name><affiliation><nlm:affiliation>University of Tennessee Health Science Center/Le Bonheur Children's Hospital, Memphis, TN, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gupta, Ruchi S" sort="Gupta, Ruchi S" uniqKey="Gupta R" first="Ruchi S" last="Gupta">Ruchi S. Gupta</name><affiliation><nlm:affiliation>Institute for Public Health and Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern School of Medicine, Chicago, IL, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Knibb, Rebecca C" sort="Knibb, Rebecca C" uniqKey="Knibb R" first="Rebecca C" last="Knibb">Rebecca C. Knibb</name><affiliation><nlm:affiliation>School of Psychology, Aston University, Birmingham, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Haselkorn, Tmirah" sort="Haselkorn, Tmirah" uniqKey="Haselkorn T" first="Tmirah" last="Haselkorn">Tmirah Haselkorn</name><affiliation><nlm:affiliation>EpiMetrix, Inc., Los Altos, CA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Tilles, Stephen" sort="Tilles, Stephen" uniqKey="Tilles S" first="Stephen" last="Tilles">Stephen Tilles</name><affiliation><nlm:affiliation>Aimmune Therapeutics, Brisbane, CA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mack, Douglas P" sort="Mack, Douglas P" uniqKey="Mack D" first="Douglas P" last="Mack">Douglas P. Mack</name><affiliation><nlm:affiliation>Department of Pediatrics, McMaster University, Hamilton, ON, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Pouessel, Guillaume" sort="Pouessel, Guillaume" uniqKey="Pouessel G" first="Guillaume" last="Pouessel">Guillaume Pouessel</name><affiliation><nlm:affiliation>Pneumology and Allergology Unit, Children's Hospital, Lille University Hospital, Jeanne de Flandre, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:33216994</idno><idno type="pmid">33216994</idno><idno type="doi">10.1111/all.14666</idno><idno type="wicri:Area/Main/Corpus">000048</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000048</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The global burden of illness of peanut allergy: A comprehensive literature review.</title><author><name sortKey="Lieberman, Jay A" sort="Lieberman, Jay A" uniqKey="Lieberman J" first="Jay A" last="Lieberman">Jay A. Lieberman</name><affiliation><nlm:affiliation>University of Tennessee Health Science Center/Le Bonheur Children's Hospital, Memphis, TN, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gupta, Ruchi S" sort="Gupta, Ruchi S" uniqKey="Gupta R" first="Ruchi S" last="Gupta">Ruchi S. Gupta</name><affiliation><nlm:affiliation>Institute for Public Health and Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern School of Medicine, Chicago, IL, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Knibb, Rebecca C" sort="Knibb, Rebecca C" uniqKey="Knibb R" first="Rebecca C" last="Knibb">Rebecca C. Knibb</name><affiliation><nlm:affiliation>School of Psychology, Aston University, Birmingham, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Haselkorn, Tmirah" sort="Haselkorn, Tmirah" uniqKey="Haselkorn T" first="Tmirah" last="Haselkorn">Tmirah Haselkorn</name><affiliation><nlm:affiliation>EpiMetrix, Inc., Los Altos, CA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Tilles, Stephen" sort="Tilles, Stephen" uniqKey="Tilles S" first="Stephen" last="Tilles">Stephen Tilles</name><affiliation><nlm:affiliation>Aimmune Therapeutics, Brisbane, CA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mack, Douglas P" sort="Mack, Douglas P" uniqKey="Mack D" first="Douglas P" last="Mack">Douglas P. Mack</name><affiliation><nlm:affiliation>Department of Pediatrics, McMaster University, Hamilton, ON, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Pouessel, Guillaume" sort="Pouessel, Guillaume" uniqKey="Pouessel G" first="Guillaume" last="Pouessel">Guillaume Pouessel</name><affiliation><nlm:affiliation>Pneumology and Allergology Unit, Children's Hospital, Lille University Hospital, Jeanne de Flandre, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Allergy</title><idno type="eISSN">1398-9995</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Peanut allergy (PA) currently affects approximately 2% of the general population of Western nations and may be increasing in prevalence. Patients with PA and their families/caregivers bear a considerable burden of self-management to avoid accidental peanut exposure and to administer emergency medication (adrenaline) if needed. Compared with other food allergies, PA is associated with higher rates of accidental exposure, severe reactions and potentially fatal anaphylaxis. Approximately 7%-14% of patients with PA experience accidental peanut exposure annually, and one-third to one-half may experience anaphylaxis, although fatalities are rare. These risks impose considerably high healthcare utilization and economic costs for patients with PA and restrictions on daily activities. Measures to accommodate patients with PA are often inadequate, with inconsistent standards for food labelling and inadequate safety policies in public establishments such as restaurants and schools. Children with PA are often bullied, resulting in sadness, humiliation and anxiety. These factors cumulatively contribute to significantly reduced health-related quality of life for patients with PA and families/caregivers. Such factors also provide essential context for risk/benefit assessments of new PA therapies. This narrative review comprehensively assessed the various factors comprising the burden of PA.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33216994</PMID><DateRevised><Year>2021</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1398-9995</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Nov</Month><Day>20</Day></PubDate></JournalIssue><Title>Allergy</Title><ISOAbbreviation>Allergy</ISOAbbreviation></Journal><ArticleTitle>The global burden of illness of peanut allergy: A comprehensive literature review.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14666</ELocationID><Abstract><AbstractText>Peanut allergy (PA) currently affects approximately 2% of the general population of Western nations and may be increasing in prevalence. Patients with PA and their families/caregivers bear a considerable burden of self-management to avoid accidental peanut exposure and to administer emergency medication (adrenaline) if needed. Compared with other food allergies, PA is associated with higher rates of accidental exposure, severe reactions and potentially fatal anaphylaxis. Approximately 7%-14% of patients with PA experience accidental peanut exposure annually, and one-third to one-half may experience anaphylaxis, although fatalities are rare. These risks impose considerably high healthcare utilization and economic costs for patients with PA and restrictions on daily activities. Measures to accommodate patients with PA are often inadequate, with inconsistent standards for food labelling and inadequate safety policies in public establishments such as restaurants and schools. Children with PA are often bullied, resulting in sadness, humiliation and anxiety. These factors cumulatively contribute to significantly reduced health-related quality of life for patients with PA and families/caregivers. Such factors also provide essential context for risk/benefit assessments of new PA therapies. This narrative review comprehensively assessed the various factors comprising the burden of PA.</AbstractText><CopyrightInformation>© 2020 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Jay A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center/Le Bonheur Children's Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Ruchi S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Institute for Public Health and Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knibb</LastName><ForeName>Rebecca C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-5561-0904</Identifier><AffiliationInfo><Affiliation>School of Psychology, Aston University, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haselkorn</LastName><ForeName>Tmirah</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>EpiMetrix, Inc., Los Altos, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tilles</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aimmune Therapeutics, Brisbane, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mack</LastName><ForeName>Douglas P</ForeName><Initials>DP</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9800-0951</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pouessel</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4118-6385</Identifier><AffiliationInfo><Affiliation>Pneumology and Allergology Unit, Children's Hospital, Lille University Hospital, Jeanne de Flandre, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Aimmune Therapeutics</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Allergy</MedlineTA><NlmUniqueID>7804028</NlmUniqueID><ISSNLinking>0105-4538</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">accidental exposure</Keyword><Keyword MajorTopicYN="N">anaphylaxis</Keyword><Keyword MajorTopicYN="N">burden</Keyword><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">peanut allergy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33216994</ArticleId><ArticleId IdType="doi">10.1111/all.14666</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Prescott SL, Pawankar R, Allen KJ, et al. A global survey of changing patterns of food allergy burden in children. World Allergy Organ J. 2013;6(1):21.</Citation></Reference><Reference><Citation>Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J Allergy Clin Immunol. 2001;107(2):367-374.</Citation></Reference><Reference><Citation>Venter C, Maslin K, Patil V, et al. The prevalence, natural history and time trends of peanut allergy over the first 10 years of life in two cohorts born in the same geographical location 12 years apart. Pediatr Allergy Immunol. 2016;27(8):804-811.</Citation></Reference><Reference><Citation>Deschildre A, Elegbede CF, Just J, et al. Peanut-allergic patients in the MIRABEL survey: characteristics, allergists' dietary advice and lessons from real life. Clin Exp Allergy. 2016;46(4):610-620.</Citation></Reference><Reference><Citation>Vereda A, van Hage M, Ahlstedt S, et al. Peanut allergy: clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol. 2011;127(3):603-607.</Citation></Reference><Reference><Citation>Leickly FE, Kloepfer KM, Slaven JE, Vitalpur G. Peanut allergy: an epidemiologic analysis of a large database. J Pediatr. 2018;192:223-228 e221.</Citation></Reference><Reference><Citation>Dyer AA, Rivkina V, Perumal D, Smeltzer BM, Smith BM, Gupta RS. Epidemiology of childhood peanut allergy. Allergy Asthma Proc. 2015;36(1):58-64.</Citation></Reference><Reference><Citation>Sicherer SH, Sampson HA. Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol. 2018;141(1):41-58.</Citation></Reference><Reference><Citation>Savage J, Johns CB. Food allergy: epidemiology and natural history. Immunol Allergy Clin North Am. 2015;35(1):45-59.</Citation></Reference><Reference><Citation>Begin P, Paradis L, Paradis J, Picard M, Des Roches A. Natural resolution of peanut allergy: a 12-year longitudinal follow-up study. J Allergy Clin Immunol Pract. 2013;1(5):528-530.e521-524.</Citation></Reference><Reference><Citation>Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol. 2010;126(6):1105-1118.</Citation></Reference><Reference><Citation>Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-1025.</Citation></Reference><Reference><Citation>Wasserman RL, Factor JM, Baker JW, et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract. 2014;2(1):91-96.</Citation></Reference><Reference><Citation>Pajno GB, Fernandez-Rivas M, Arasi S, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73(4):799-815.</Citation></Reference><Reference><Citation>Shaker M, Greenhawt M. Peanut allergy: burden of illness. Allergy Asthma Proc. 2019;40(5):290-294.</Citation></Reference><Reference><Citation>Venter C, Sicherer SH, Greenhawt M. Management of peanut allergy. J Allergy Clin Immunol Pract. 2019;7(2):345-355 e342.</Citation></Reference><Reference><Citation>Avery NJ, King RM, Knight S, Hourihane JO. Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol. 2003;14(5):378-382.</Citation></Reference><Reference><Citation>King RM, Knibb RC, Hourihane JO. Impact of peanut allergy on quality of life, stress and anxiety in the family. Allergy. 2009;64(3):461-468.</Citation></Reference><Reference><Citation>Roy KM, Roberts MC. Peanut allergy in children: relationships to health-related quality of life, anxiety, and parental stress. Clin Pediatr (Phila). 2011;50(11):1045-1051.</Citation></Reference><Reference><Citation>Cherkaoui S, Ben-Shoshan M, Alizadehfar R, et al. Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy. Clin Transl Allergy. 2015;5:16.</Citation></Reference><Reference><Citation>Shaker M, Greenhawt M. Association of fatality risk with value-based drug pricing of epinephrine autoinjectors for children with peanut allergy: a cost-effectiveness analysis. JAMA Netw Open. 2018;1(7):e184728.</Citation></Reference><Reference><Citation>Loh W, Tang MLK. The epidemiology of food allergy in the global context. Int J Environ Res Public Health. 2018;15(9):2043.</Citation></Reference><Reference><Citation>Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803-813.</Citation></Reference><Reference><Citation>Turner PJ, Campbell DE, Boyle RJ, Levin ME. Primary prevention of food allergy: translating evidence from clinical trials to population-based recommendations. J Allergy Clin Immunol Pract. 2018;6(2):367-375.</Citation></Reference><Reference><Citation>Fleischer DM, Sicherer S, Greenhawt M, et al. Consensus communication on early peanut introduction and prevention of peanut allergy in high-risk infants. Pediatr Dermatol. 2016;33(1):103-106.</Citation></Reference><Reference><Citation>Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017;139(1):29-44.</Citation></Reference><Reference><Citation>Aimmune Therapeutics Inc. Full Prescribing Information for PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp]. Brisbane, CA: Aimmune Therapeutics Inc.; 2020.</Citation></Reference><Reference><Citation>PALISADE Group of Clinical Investigators, Vickery B, Vereda A, et al. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;379(21):1991-2001.</Citation></Reference><Reference><Citation>Duca B, Patel N, Turner PJ. GRADE-ing the benefit/risk equation in food immunotherapy. Curr Allergy Asthma Rep. 2019;19(6):30.</Citation></Reference><Reference><Citation>Vickery BP, Hourihane JO, Adelman DC. Oral immunotherapy for peanut allergy. N Engl J Med. 2019;380(7):691-692.</Citation></Reference><Reference><Citation>Fleischer DM, Greenhawt M, Sussman G, et al. Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial. JAMA. 2019;321(10):946-955.</Citation></Reference><Reference><Citation>Licari A, Manti S, Marseglia A, et al. Food allergies: current and future treatments. Medicina (Kaunas, Lithuania). 2019;55(5):120.</Citation></Reference><Reference><Citation>Botha M, Basera W, Facey-Thomas HE, et al. Rural and urban food allergy prevalence from the South African Food Allergy (SAFFA) study. J Allergy Clin Immunol. 2019;143(2):662-668 e662.</Citation></Reference><Reference><Citation>Ziyab AH. Prevalence of food allergy among schoolchildren in Kuwait and its association with the coexistence and severity of asthma, rhinitis, and eczema: a cross-sectional study. World Allergy Organ J. 2019;12(4):100024.</Citation></Reference><Reference><Citation>Liew WK, Chiang WC, Goh AE, et al. Paediatric anaphylaxis in a Singaporean children cohort: changing food allergy triggers over time. Asia Pac Allergy. 2013;3(1):29-34.</Citation></Reference><Reference><Citation>Goh DL, Lau YN, Chew FT, Shek LP, Lee BW. Pattern of food-induced anaphylaxis in children of an Asian community. Allergy. 1999;54(1):84-86.</Citation></Reference><Reference><Citation>Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol. 2010;125(6):1322-1326.</Citation></Reference><Reference><Citation>Kotz D, Simpson CR, Sheikh A. Incidence, prevalence, and trends of general practitioner-recorded diagnosis of peanut allergy in England, 2001 to 2005. J Allergy Clin Immunol. 2011;127(3):623-630 e621.</Citation></Reference><Reference><Citation>Mahr TA Lieberman, JA, Haselkorn T. et al. Characteristics of peanut allergy diagnosis in a US healthcare claims database (2011-2017) J Allergy Clin Immunol Pract. In press.</Citation></Reference><Reference><Citation>Gupta RS, Warren CM, Smith BM, et al. The public health impact of parent-reported childhood food allergies in the United States. Pediatrics. 2018;142(6):e20181235.</Citation></Reference><Reference><Citation>Gupta RS, Warren CM, Smith BM, et al. Prevalence and severity of food allergies among US adults. JAMA Netw Open. 2019;2(1):e185630.</Citation></Reference><Reference><Citation>Mullins RJ, Dear KB, Tang ML. Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. J Allergy Clin Immunol. 2009;123(3):689-693.</Citation></Reference><Reference><Citation>Bunyavanich S, Rifas-Shiman SL, Platts-Mills TA, et al. Peanut allergy prevalence among school-age children in a US cohort not selected for any disease. J Allergy Clin Immunol. 2014;134(3):753-755.</Citation></Reference><Reference><Citation>Scott LA, Jones BI, Berni TR, Berni ER, De Vries J, Currie CJ. Evaluation of the epidemiology of peanut allergy in the United Kingdom. Expert Rev Clin Immunol. 2019;15(12):1333-1339.</Citation></Reference><Reference><Citation>Ben-Shoshan M, Kagan RS, Alizadehfar R, et al. Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal. J Allergy Clin Immunol. 2009;123(4):783-788.</Citation></Reference><Reference><Citation>Clarke AE, Elliott S, Pierre YS, Soller L, La Vieille S, Ben-Shoshan M. Temporal trends in prevalence of food allergy in Canada. J Allergy Clin Immunol Pract. 2020;8(4):1428-1430.e5.</Citation></Reference><Reference><Citation>Venter C, Hasan Arshad S, Grundy J, et al. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK. Allergy. 2010;65(1):103-108.</Citation></Reference><Reference><Citation>Sicherer SH, Furlong TJ, Munoz-Furlong A, Burks AW, Sampson HA. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol. 2001;108(1):128-132.</Citation></Reference><Reference><Citation>Neuman-Sunshine DL, Eckman JA, Keet CA, et al. The natural history of persistent peanut allergy. Ann Allergy Asthma Immunol. 2012;108(5):326-331 e323.</Citation></Reference><Reference><Citation>Nguyen-Luu NU, Ben-Shoshan M, Alizadehfar R, et al. Inadvertent exposures in children with peanut allergy. Pediatr Allergy Immunol. 2012;23(2):133-139.</Citation></Reference><Reference><Citation>Yu JW, Kagan R, Verreault N, et al. Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol. 2006;118(2):466-472.</Citation></Reference><Reference><Citation>Sicherer SH, Burks AW, Sampson HA. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics. 1998;102(1):e6.</Citation></Reference><Reference><Citation>Vander Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr. 2000;137(6):749-755.</Citation></Reference><Reference><Citation>Grabenhenrich LB, Dolle S, Moneret-Vautrin A, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137(4):1128-1137.</Citation></Reference><Reference><Citation>McWilliam VL, Koplin JJ, Field MJ, et al. Self-reported adverse food reactions and anaphylaxis in the SchoolNuts study: a population-based study of adolescents. J Allergy Clin Immunol. 2018;141(3):982-990.</Citation></Reference><Reference><Citation>Pouessel G, Antoine M, Lejeune S, et al. The time course of anaphylaxis manifestations in children is diverse and unpredictable. Clin Exp Allergy. 2020;50(1):117-120.</Citation></Reference><Reference><Citation>Ramsey NB, Guffey D, Anagnostou K, Coleman NE, Davis CM. Epidemiology of anaphylaxis in critically ill children in the United States and Canada. J Allergy Clin Immunol Pract. 2019;7(7):2241-2249.</Citation></Reference><Reference><Citation>Pouessel G, Chagnon F, Trochu C, et al. Anaphylaxis admissions to pediatric intensive care units in France. Allergy. 2018;73(9):1902-1905.</Citation></Reference><Reference><Citation>Parlaman JP, Oron AP, Uspal NG, DeJong KN, Tieder JS. Emergency and hospital care for food-related anaphylaxis in children. Hosp Pediatr. 2016;6(5):269-274.</Citation></Reference><Reference><Citation>Scott LA, Berni TR, Berni ER, De Vries J, Currie CJ. Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom. Expert Rev Clin Immunol. 2019;15(8):889-896.</Citation></Reference><Reference><Citation>Dyer AA, Lau CH, Smith TL, Smith BM, Gupta RS. Pediatric emergency department visits and hospitalizations due to food-induced anaphylaxis in Illinois. Ann Allergy Asthma Immunol. 2015;115(1):56-62.</Citation></Reference><Reference><Citation>Nocerino R, Leone L, Cosenza L, Berni Canani R. Increasing rate of hospitalizations for food-induced anaphylaxis in Italian children: an analysis of the Italian Ministry of Health database. J Allergy Clin Immunol. 2015;135(3):833-835 e833.</Citation></Reference><Reference><Citation>Patel DA, Holdford DA, Edwards E, Carroll NV. Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States. J Allergy Clin Immunol. 2011;128(1):110-115 e115.</Citation></Reference><Reference><Citation>Gupta R, Holdford D, Bilaver L, Dyer A, Holl JL, Meltzer D. The economic impact of childhood food allergy in the United States. JAMA Pediatr. 2013;167(11):1026-1031.</Citation></Reference><Reference><Citation>Fox M, Mugford M, Voordouw J, et al. Health sector costs of self-reported food allergy in Europe: a patient-based cost of illness study. Eur J Public Health. 2013;23(5):757-762.</Citation></Reference><Reference><Citation>FAIR Health. Food Allergy in the United States: Recent Trends and Costs. New York, NY: FAIR Health, Inc.; 2017.</Citation></Reference><Reference><Citation>Diwakar L, Cummins C, Ryan R, Marshall T, Roberts T. Prescription rates of adrenaline auto-injectors for children in UK general practice: a retrospective cohort study. Br J Gen Pract. 2017;67(657):e300-e305.</Citation></Reference><Reference><Citation>Protudjer JL, Jansson SA, Heibert Arnlind M, et al. Household costs associated with objectively diagnosed allergy to staple foods in children and adolescents. J Allergy Clin Immunol Pract. 2015;3(1):68-75.</Citation></Reference><Reference><Citation>Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107(1):191-193.</Citation></Reference><Reference><Citation>Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119(4):1016-1018.</Citation></Reference><Reference><Citation>Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380-384.</Citation></Reference><Reference><Citation>Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol. 2004;4(4):285-290.</Citation></Reference><Reference><Citation>Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol. 2007;119(4):1018-1019.</Citation></Reference><Reference><Citation>Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016;46(8):1099-1110.</Citation></Reference><Reference><Citation>Pouessel G, Tanno LK, Claverie C, et al. Fatal anaphylaxis in children in France: analysis of national data. Pediatr Allergy Immunol. 2018;29(1):101-104.</Citation></Reference><Reference><Citation>Umasunthar T, Leonardi-Bee J, Hodes M, et al. Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2013;43(12):1333-1341.</Citation></Reference><Reference><Citation>Pouessel G, Turner PJ, Worm M, et al. Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies. Clin Exp Allergy. 2018;48(12):1584-1593.</Citation></Reference><Reference><Citation>Yang LCS, Joks R. A retrospective study of peanut and tree nut allergy: sensitization and correlations with clinical manifestations. Allergy Rhinol (Providence). 2015;6(1):39-43.</Citation></Reference><Reference><Citation>Weinberger T, Sicherer S. Current perspectives on tree nut allergy: a review. J Asthma Allergy. 2018;11:41-51.</Citation></Reference><Reference><Citation>Soller L, Clarke AE, Lyttle A, et al. Comparing quality of life in Canadian children with peanut, sesame, and seafood allergy. J Allergy Clin Immunol Pract. 2020;8(1):352-354.e351.</Citation></Reference><Reference><Citation>Beck C, Koplin J, Dharmage S, et al. Persistent food allergy and food allergy coexistent with eczema is associated with reduced growth in the first 4 years of life. J Allergy Clin Immunol Pract. 2016;4(2):248-256 e243.</Citation></Reference><Reference><Citation>Skypala IJ, McKenzie R. Nutritional issues in food allergy. Clin Rev Allergy Immunol. 2019;57(2):166-178.</Citation></Reference><Reference><Citation>Mehta H, Groetch M, Wang J. Growth and nutritional concerns in children with food allergy. Curr Opin Allergy Clin Immunol. 2013;13(3):275-279.</Citation></Reference><Reference><Citation>Elizur A, Appel MY, Nachshon L, et al. NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) study. Allergy. 2018;73(3):593-601.</Citation></Reference><Reference><Citation>Brough HA, Caubet JC, Mazon A, et al. Defining challenge-proven coexistent nut and sesame seed allergy: a prospective multicenter European study. J Allergy Clin Immunol. 2020;145(4):1231-1239.</Citation></Reference><Reference><Citation>Yeung J, Robert MC. Challenges and path forward on mandatory allergen labeling and voluntary precautionary allergen labeling for a global company. J AOAC Int. 2018;101(1):70-76.</Citation></Reference><Reference><Citation>Pieretti MM, Chung D, Pacenza R, Slotkin T, Sicherer SH. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol. 2009;124(2):337-341.</Citation></Reference><Reference><Citation>Battisti C, Chambefort A, Digaud O, et al. Allergens labeling on French processed foods - an Oqali study. Food Sci Nutr. 2017;5(4):881-888.</Citation></Reference><Reference><Citation>Watts R, Humphries W, Ellery B, Ellson A. One in five food samples contains a hidden allergen. The Times. 2020.</Citation></Reference><Reference><Citation>Blom WM, Michelsen-Huisman AD, van Os-Medendorp H, et al. Accidental food allergy reactions: products and undeclared ingredients. J Allergy Clin Immunol. 2018;142(3):865-875.</Citation></Reference><Reference><Citation>Ford LS, Taylor SL, Pacenza R, Niemann LM, Lambrecht DM, Sicherer SH. Food allergen advisory labeling and product contamination with egg, milk, and peanut. J Allergy Clin Immunol. 2010;126(2):384-385.</Citation></Reference><Reference><Citation>Hefle SL, Furlong TJ, Niemann L, Lemon-Mule H, Sicherer S, Taylor SL. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts. J Allergy Clin Immunol. 2007;120(1):171-176.</Citation></Reference><Reference><Citation>Marchisotto MJ, Harada L, Kamdar O, et al. Food allergen labeling and purchasing habits in the United States and Canada. J Allergy Clin Immunol Pract. 2017;5(2):345-351 e342.</Citation></Reference><Reference><Citation>DunnGalvin A, Chan CH, Crevel R, et al. Precautionary allergen labelling: perspectives from key stakeholder groups. Allergy. 2015;70(9):1039-1051.</Citation></Reference><Reference><Citation>DunnGalvin A, Cullinane C, Daly DA, Flokstra-de Blok BM, Dubois AE, Hourihane JO. Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire - parent form in children 0-12 years following positive and negative food challenges. Clin Exp Allergy. 2010;40(3):476-485.</Citation></Reference><Reference><Citation>DunnGalvin A, Hourihane JOB. Developmental aspects of HRQL in food related chronic disease. In: Preedy VR, Watson RR, Martin CR, eds. The International Handbook of Behaviour, Diet and Nutrition. New York, NY: Springer; 2011:3077-3098.</Citation></Reference><Reference><Citation>Miles S, Frewer LJ. Public perceptions of scientific uncertainty in relation to food hazards. J Risk Res. 2011;6(3):268-283.</Citation></Reference><Reference><Citation>Voordouw J, Antonides G, Fox M, et al. The direct and indirect costs associated with food hypersensitivity in households: a study in the Netherlands, Poland, and Spain. Appl Stud Agribus Comm. 2016;10(2-3):107-118.</Citation></Reference><Reference><Citation>Sicherer SH, Allen K, Lack G, Taylor SL, Donovan SM, Oria M. Critical Issues in food allergy: a National Academies consensus report. Pediatrics. 2017;140(2):e20170194.</Citation></Reference><Reference><Citation>Food: EU consumers to benefit from better labelling as of 13 December 2014 [press release]. Brussels, Belgium: European Commission; 2014.</Citation></Reference><Reference><Citation>The European Federation of Allergy and Airways Diseases Patients’ Associations. Quality of Life for People with Food Allergies in Europe: A Menu for Improvement. 2019; https://www.efanet.org/images/2019/FD_FINAL.pdf. Accessed May 7, 2020.</Citation></Reference><Reference><Citation>Furlong TJ, DeSimone J, Sicherer SH. Peanut and tree nut allergic reactions in restaurants and other food establishments. J Allergy Clin Immunol. 2001;108(5):867-870.</Citation></Reference><Reference><Citation>Bailey S, Albardiaz R, Frew AJ, Smith H. Restaurant staff's knowledge of anaphylaxis and dietary care of people with allergies. Clin Exp Allergy. 2011;41(5):713-717.</Citation></Reference><Reference><Citation>Lee YM, Xu H. Food allergy knowledge, attitudes, and preparedness among restaurant managerial staff. J Foodsrv Bus Res. 2015;18(5):454-469.</Citation></Reference><Reference><Citation>Radke TJ, Brown LG, Hoover ER, et al. Food allergy knowledge and attitudes of restaurant managers and staff: An EHS-Net study. J Food Prot. 2016;79(9):1588-1598.</Citation></Reference><Reference><Citation>Sogut A, Kavut AB, Kartal I, et al. Food allergy knowledge and attitude of restaurant personnel in Turkey. Int Forum Allergy Rhinol. 2015;5(2):157-161.</Citation></Reference><Reference><Citation>Common LA, Corrigan CJ, Smith H, Bailey S, Harris S, Holloway JA. How safe is your curry? Food allergy awareness of restaurant staff. J Allergy Ther. 2013;4(4):1-4.</Citation></Reference><Reference><Citation>Dupuis R, Meisel Z, Grande D, et al. Food allergy management among restaurant workers in a large US city. Food Control. 2016;63:147-157.</Citation></Reference><Reference><Citation>Shafie AA, Azman AW. Assessment of knowledge, attitude and practice of food allergies among food handlers in the state of Penang, Malaysia. Public Health. 2015;129(9):1278-1284.</Citation></Reference><Reference><Citation>Begen FM, Barnett J, Payne R, Roy D, Gowland MH, Lucas JS. Consumer preferences for written and oral information about allergens when eating out. PLoS One. 2016;11(5):e0156073.</Citation></Reference><Reference><Citation>Bollinger ME, Dahlquist LM, Mudd K, Sonntag C, Dillinger L, McKenna K. The impact of food allergy on the daily activities of children and their families. Ann Allergy Asthma Immunol. 2006;96(3):415-421.</Citation></Reference><Reference><Citation>Barnett J, Botting N, Gowland MH, Lucas JS. The strategies that peanut and nut-allergic consumers employ to remain safe when travelling abroad. Clin Transl Allergy. 2012;2(1):12.</Citation></Reference><Reference><Citation>Greenhawt M, MacGillivray F, Batty G, Said M, Weiss C. International study of risk-mitigating factors and in-flight allergic reactions to peanut and tree nut. J Allergy Clin Immunol Pract. 2013;1(2):186-194.</Citation></Reference><Reference><Citation>Nwaru BI, Hickstein L, Panesar SS, et al. Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy. 2014;69(8):992-1007.</Citation></Reference><Reference><Citation>Pouessel G, Dumond P, Liabeuf V, et al. Gaps in the management of food-induced anaphylaxis reactions at school. Pediatr Allergy Immunol. 2019;30(7):767-770.</Citation></Reference><Reference><Citation>Kilger M, Range U, Vogelberg C. Acute and preventive management of anaphylaxis in German primary school and kindergarten children. BMC Pediatr. 2015;15:159.</Citation></Reference><Reference><Citation>Nowak-Wegrzyn A, Conover-Walker M, Wood RA. Food-allergic reactions in schools and preschools. Arch Pediatr Adolesc Med. 2001;155(7):790-795.</Citation></Reference><Reference><Citation>Sicherer SH, Furlong TJ, DeSimone J, Sampson HA. The US Peanut and Tree Nut Allergy Registry: characteristics of reactions in schools and day care. J Pediatr. 2001;138(4):560-565.</Citation></Reference><Reference><Citation>Polloni L, Lazzarotto F, Toniolo A, Ducolin G, Muraro A. What do school personnel know, think and feel about food allergies? Clin Transl Allergy. 2013;3(1):39.</Citation></Reference><Reference><Citation>Twichell S, Wang K, Robinson H, Acebal M, Sharma H. Food allergy knowledge and attitudes among school nurses in an urban public school district. Children (Basel). 2015;2(3):330-341.</Citation></Reference><Reference><Citation>Canon N, Gharfeh M, Guffey D, Anvari S, Davis CM. Role of food allergy education: measuring teacher knowledge, attitudes, and beliefs. Allergy Rhinol (Providence). 2019;10:2152656719856324.</Citation></Reference><Reference><Citation>White MV, Hogue SL, Odom D, et al. Anaphylaxis in schools: Results of the EPIPEN4SCHOOLS Survey combined analysis. Pediatr Allergy Immunol Pulmonol. 2016;29(3):149-154.</Citation></Reference><Reference><Citation>Hogue SL, Muniz R, Herrem C, Silvia S, White MV. Barriers to the administration of epinephrine in schools. J Sch Health. 2018;88(5):396-404.</Citation></Reference><Reference><Citation>Stukus DR. Peanut-free schools: What does it really mean, and are they necessary? J Allergy Clin Immunol. 2017;140(2):391-392.</Citation></Reference><Reference><Citation>Bartnikas LM, Huffaker MF, Sheehan WJ, et al. Impact of school peanut-free policies on epinephrine administration. J Allergy Clin Immunol. 2017;140(2):465-473.</Citation></Reference><Reference><Citation>Kao LM, Wang J, Kagan O, et al. School nurse perspectives on school policies for food allergy and anaphylaxis. Ann Allergy Asthma Immunol. 2018;120(3):304-309.</Citation></Reference><Reference><Citation>Murdoch B, Adams EM, Caulfield T. The law of food allergy and accommodation in Canadian schools. Allergy Asthma Clin Immunol. 2018;14:67.</Citation></Reference><Reference><Citation>Bartnikas LM, Huffaker MF, Sheehan WJ, et al. Racial and socioeconomic differences in school peanut-free policies. J Allergy Clin Immunol Pract. 2020;8(1):340-342 e341.</Citation></Reference><Reference><Citation>Patel DR, Upton JEM, Wang J, et al. Quality of life for parents of children with food allergy in peanut-restricted versus peanut-free schools in the United States and Canada. J Allergy Clin Immunol Pract. 2018;6(2):671-673 e677.</Citation></Reference><Reference><Citation>Chad L, Ben-Shoshan M, Asai Y, et al. A majority of parents of children with peanut allergy fear using the epinephrine auto-injector. Allergy. 2013;68(12):1605-1609.</Citation></Reference><Reference><Citation>Cummings AJ, Knibb RC, Erlewyn-Lajeunesse M, King RM, Roberts G, Lucas JS. Management of nut allergy influences quality of life and anxiety in children and their mothers. Pediatr Allergy Immunol. 2010;21(4 Pt 1):586-594.</Citation></Reference><Reference><Citation>Ward CE, Greenhawt MJ. Treatment of allergic reactions and quality of life among caregivers of food-allergic children. Ann Allergy Asthma Immunol. 2015;114(4):312-318 e312.</Citation></Reference><Reference><Citation>Shaker MS, Schwartz J, Ferguson M. An update on the impact of food allergy on anxiety and quality of life. Curr Opin Pediatr. 2017;29(4):497-502.</Citation></Reference><Reference><Citation>Fong AT, Katelaris CH, Wainstein B. Bullying and quality of life in children and adolescents with food allergy. J Paediatr Child Health. 2017;53(7):630-635.</Citation></Reference><Reference><Citation>Lieberman JA, Weiss C, Furlong TJ, Sicherer M, Sicherer SH. Bullying among pediatric patients with food allergy. Ann Allergy Asthma Immunol. 2010;105(4):282-286.</Citation></Reference><Reference><Citation>Polloni L, Ferruzza E, Ronconi L, et al. Mental health and behavior of food-allergic adolescents compared to a healthy matched sample. Ann Allergy Asthma Immunol. 2015;115(2):158-160.</Citation></Reference><Reference><Citation>DunnGalvin A, Dubois AE, Flokstra-de Blok BM, Hourihane JO. The effects of food allergy on quality of life. Chem Immunol Allergy. 2015;101:235-252.</Citation></Reference><Reference><Citation>Knibb RC, Ibrahim NF, Petley R, et al. Validation of the Paediatric Food Allergy Quality of Life Questionnaire (PFA-QL). Pediatr Allergy Immunol. 2013;24(3):288-292.</Citation></Reference><Reference><Citation>Fedele DA, McQuaid EL, Faino A, et al. Patterns of adaptation to children's food allergies. Allergy. 2016;71(4):505-513.</Citation></Reference><Reference><Citation>Ward C, Greenhawt M. Differences in caregiver food allergy quality of life between tertiary care, specialty clinic, and caregiver-reported food allergic populations. J Allergy Clin Immunol Pract. 2016;4(2):257-264 e253.</Citation></Reference><Reference><Citation>Liu AH, Jaramillo R, Sicherer SH, et al. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2010;126(4):798-806 e713.</Citation></Reference><Reference><Citation>Ben-Shoshan M, Harrington DW, Soller L, et al. A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada. J Allergy Clin Immunol. 2010;125(6):1327-1335.</Citation></Reference><Reference><Citation>Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics. 2011;128(1):e9-e17.</Citation></Reference><Reference><Citation>Osborne NJ, Koplin JJ, Martin PE, et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol. 2011;127(3):668-676 e661-662.</Citation></Reference><Reference><Citation>McGowan EC, Keet CA. Prevalence of self-reported food allergy in the National Health and Nutrition Examination Survey (NHANES) 2007-2010. J Allergy Clin Immunol. 2013;132(5):1216-1219 e1215.</Citation></Reference><Reference><Citation>Peters RL, Koplin JJ, Gurrin LC, et al. The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up. J Allergy Clin Immunol. 2017;140(1):145-153 e148.</Citation></Reference><Reference><Citation>Bedolla-Barajas M, Valdez-Lopez F, Alcala-Padilla G, Bedolla-Pulido TI, Rivera-Mejia V, Morales-Romero J. Prevalence and factors associated to peanut allergy in Mexican school children. Allergol Immunopathol (Madr). 2017;45(1):69-76.</Citation></Reference><Reference><Citation>Kim M, Lee JY, Jeon HY, et al. Prevalence of immediate-type food allergy in Korean schoolchildren in 2015: a Nationwide Population-based Study. Allergy Asthma Immunol Res. 2017;9(5):410-416.</Citation></Reference><Reference><Citation>Sasaki M, Koplin JJ, Dharmage SC, et al. Prevalence of clinic-defined food allergy in early adolescence: the SchoolNuts study. J Allergy Clin Immunol. 2018;141(1):391-398 e394.</Citation></Reference><Reference><Citation>Lieberman J, Sublett J, Ali Y, et al. Increased incidence and prevalence of peanut allergy in children and adolescents in the United States. Ann Allergy Asthma Immunol. 2018;121(5):S13.</Citation></Reference><Reference><Citation>Gonzales-Gonzalez VA, Diaz AM, Fernandez K, Rivera MF. Prevalence of food allergens sensitization and food allergies in a group of allergic Honduran children. Allergy Asthma Clin Immunol. 2018;14:23.</Citation></Reference><Reference><Citation>Simons E, Balshaw R, Lefebvre DL, et al. Timing of introduction, sensitization and allergy to highly-allergenic foods at age 3 years in a general-population Canadian cohort. J Allergy Clin Immunol Pract. 2020;8:166-175.e10</Citation></Reference><Reference><Citation>Johnston DT, Sher L, Fineman SM, et al. Prevalence of comorbidities with peanut allergy: results from a phase 3, randomized, double-blind, placebo-controlled trial (PALISADE). J Allergy Clin Immunol. 2019;143(2):AB270.</Citation></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000048 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000048 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:33216994
|texte= The global burden of illness of peanut allergy: A comprehensive literature review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33216994" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |